UAML
TEVA icon

Unifi Asset Management LP’s Teva Pharmaceuticals TEVA Stock Holding History

Unifi Asset Management LP’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,753
Closed -$835K – 110
2025
Q4 		$835K Buy
+26,753
New +$659K 0.57% 41

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Unifi Asset Management LP's TEVA Position: Q1 2026 in Review

Unifi Asset Management LP sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 26,753 shares — an estimated $835K sold.

Unifi Asset Management LP first reported a position in TEVA in Q4 2025 and held it in 1 quarter. The position peaked at $835K in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Unifi Asset Management LP reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Unifi Asset Management LP sold 26,753 Teva Pharmaceuticals shares in Q1 2026, an estimated $835K.
  • Unifi Asset Management LP first reported a position in Teva Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Unifi Asset Management LP's Teva Pharmaceuticals position peaked at $835K in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Unifi Asset Management LP's 13F filing for Q1 2026, filed 7 Aug 2026.